Abbott, Reckitt and Mead Johnson

Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead
A lawyer for a Missouri mother on Wednesday asked a jury to make Abbott and Reckitt's Mead Johnson pay a total of more than $6 billion in the latest trial over claims that the companies' formulas for premature babies caused a severe intestinal illness.
Abbott, Reckitt Score First Victory in Baby Formula Trial
Abbott Laboratories and a unit of Reckitt Benckiser Group Plc were cleared by a jury over claims they hid risks their premature-infant formulas can cause a bowel disease that severely sickened a baby boy.
Abbott, Mead Johnson Win Defense Verdict Over Preemie Infant Formula
In closing arguments on Wednesday, plaintiff's lawyer Timothy Cronin asked jurors for $6 billion in punitive damages.
Abbott and Reckitt unit secure win in infant formula trial
Abbott and Reckitt's unit Mead Johnson are not responsible for a young boy's debilitating intestinal disease, a jury found on Thursday in a lawsuit that accused the companies of failing to warn of the risks of premature baby formulas.
Abbott, Reckitt Cleared of Liability in Latest Preterm Formula Case
(Reuters) -Abbott and Reckitt unit Mead Johnson are not responsible for a young boy's debilitating intestinal disease, a jury found on Thursday in a lawsuit accusing them of failing to warn of their premature baby formulas' risks,
Reckitt, Abbott surge after winning an NEC case
A jury ruled on Thursday that Abbott Laboratories (NYSE:ABT) and Mead Johnson, a division of Reckitt Benckiser (LON:RKT), are not liable for a young boy's severe intestinal disease, marking a significant win for the
Abbott shares rise after securing first win in premature infant formula trial
Abbott Laboratories shares rose nearly 5% before the bell on Friday, after a jury cleared the company and a Reckitt unit of liability in a lawsuit over their premature baby formulas' risks.
Abbott jumps as jury says company, Reckitt not liable in infant formula case
"We are pleased with the jury’s decision," Abbott said in a statement emailed to Seeking Alpha. "The decision reinforces ...
St. Louis jury finds formula companies not liable for illness of premature infant
A St. Louis jury on Thursday ruled that two major formula makers and a local hospital were not liable for the severe ...
If You're On Ozempic, Experts Say You're Probably Not Getting Enough Protein
For people taking weight-loss drugs like Ozempic, it's especially important for them to be eating more protein. 'WH' sat down ...
Will glucose monitors become the next wellness accessory? Abbott Laboratories moves beyond diabetes with new device
A new device from Abbott Laboratories, called Lingo, is geared toward people who don’t have diabetes but want to see how food ...
What Drove Abbott's Q3?
Abbott (NYSE: ABT) recently reported its Q3 results, with revenues and earnings slightly above our expectations.
Dairy Reporter12h
Mead Johnson, Abbott Laboratories cleared in NEC trial
The infant formula manufacturers were facing $6.2bn in punitive damages over allegations their infant formula products caused ...
Abbott Laboratories: Promising Growth, Yet Fully Valued; A Wait-And-Watch Stock
Abbott Laboratories, a healthcare giant with diverse divisions, is normalizing post-pandemic as its medical devices drive ...
CSR Wire9d
Helping People Recover From Devastating Hurricanes
To help affected families and communities, Abbott and Abbott Fund are working with our longstanding disaster relief partner ...